Although the product has been shown to be safe, there is no evidence whatsoever that it should be taken by anyone who does not have mild or early stage Alzheimer's disease, Hughes said.

CNN: Nutritional drink, imaging show promise for Alzheimer's

Rinat, a spinoff of Genentech, had been in a bidding war to partner with one of nine interested pharmaceutical firms for a promising but very early stage drug candidate to treat Alzheimer's.

FORBES: Magazine Article

Rinat, a spinoff of Genentech (nyse: DNA - news - people ), had been in a bidding war to partner with one of nine interested pharmaceutical firms for a promising but very early stage drug candidate to treat Alzheimer's.

FORBES: Biology Rising